Atara Biotherapeutics, Inc.
ATRA·NasdaqGS
9.38−0.10 (−1.05%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close9.48
Open9.35
Day range8.999.58
52-week range3.9219.15
Off day high−2.09%
Off 52-week high−51.01%
Volume26.84K
Avg. volume (3M)51.38K
Market cap94.15M
EPS (TTM)-1.30
Forward P/E6.07
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding10.04M
Short interest—
Earnings dateAug 12, 2026 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| ATRA | AUTL | ETRA | HURA | IPSC | ANIX | |
|---|---|---|---|---|---|---|
| Market cap | 94.15M | 463.12M | 584.99M | 121.08M | 260.75M | 98.73M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 6.1 | -2.8 | — | -3.1 | -3.2 | -9.2 |
| Price/book | -2.4 | 6.2 | 0.0 | 6.6 | 1.1 | 6.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −35.80% | +7.41% | −31.77% | −19.34% | +167.27% | −34.41% |
| Today | −1.05% | −3.87% | +3.10% | −3.06% | −2.04% | −2.07% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ATRA news ›Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration
BioSpace Atara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug Administration THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Themes
Most coverage from
-
biospace.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.